EMPD Form 4: 298,802 performance options for director tied to VWAP
Rhea-AI Filing Summary
Empery Digital Inc. (EMPD) director Matthew Homer reported the acquisition of 298,802 stock options on 07/17/2025 with an exercise price of $10. The filing lists the options as directly beneficially owned following the transaction and shows a contractual vesting schedule tied to the company’s daily VWAP: 20% vests when VWAP reaches $10 and additional 20% tranches thereafter until fully vested at a VWAP of $30. All vesting is subject to stockholder approval of a new option plan. The Form 4 is signed by the reporting person on 08/21/2025.
Positive
- Large performance-based grant aligns the director's incentives with shareholder value by vesting only as VWAP milestones ($10 to $30) are met
- Direct beneficial ownership reported, indicating the director holds the granted options personally
Negative
- Vesting contingent on shareholder approval of a new stock option plan, creating execution risk if approval is not obtained
- Potential dilution from 298,802 options if exercised; the filing does not disclose total shares outstanding or percentage impact
Insights
TL;DR Director received a large option grant with performance-based vesting tied to VWAP and contingent on shareholder approval.
The reported grant of 298,802 options at a $10 strike is a significant equity award to an insider that will only vest as the stock reaches specified VWAP milestones up to $30. That structure aligns the director’s potential upside with stock-price performance rather than time-based vesting. Requiring stockholder approval for the new option plan creates execution risk: if shareholders do not approve the plan, vesting may not occur. The filing reports direct beneficial ownership of the options following the grant, and the Form 4 was signed on 08/21/2025.
TL;DR The grant is performance-conditioned and contingent on a new plan, raising governance and dilution considerations.
The VWAP-triggered vesting schedule is performance-oriented, which can be preferable to guaranteed grants, but the contingency requiring shareholder approval means governance outcomes will determine whether the award becomes effective. Investors should note potential dilution if the plan is approved and options are exercised. The filing does not disclose the total option pool or percentage dilution, so materiality relative to outstanding shares cannot be assessed from this Form 4 alone.